FACULTY PROFILES
“Get to know our exceptional faculty members – experts in their field, passionate educators, and dedicated mentors. Discover their backgrounds, research interests, and teaching philosophies.”
| S.No. | Name | Subject Taught | Area of Research | Description |
|---|---|---|---|---|
| 1 | NIDA M SIDDIQUI | INDUSTRIAL PHARMACY I, NDDS | Formulation development & evaluation (pharmaceutics) | Formulation development & their evaluation parameters in novel drug delivery systems |
| 2 | Khushboo Khan | Pharmacotherapeutics community | Neurological disorders | nan |
| 3 | Akash Srivastava | Pharmaceutics | Nanoformulation | In master’s work related to development and evaluation of niosomal gel containing combination of antifungal drugs has done and also currently involved in study of niosomal gel containing Phlorizin and curcumin for wound healing in diabetic rats. |
| 4 | Ali Abbas Rizvi | Industrial Pharmacy-I | Nanoformulation | nan |
| 5 | Ashutosh Kumar Yadav | Pharmacology | Prevention of Induced Cognitive Impairment by Selected Natural Products | Chemotherapeutic agents on chronic use causing cognitive impairment which affects the quality of life of cancer survivors. The chemobrain or chemofog is the major issues associated with chemotherapy that needs to be focused and treated during the chemotherapy by the use of natural products. |
| 6 | Sakshi Srivastava | Pharmacology | Hepatoprotectivity against chemotherapy agents | The hepatoprotectivity of medicinal plant extracts will be evaluated against chemotherapy agents like Methotrexate and Rifampin and Isoniazid induced hepatotoxicity. |
| 7 | Alok Kumar Srivastava | Pharmacotherapeutics, Clinical Pharmacy | Metabolic disorders, clinical research, preclinical research, pharmacovogilance & pharmacoepidemiology | I am specialized pharmacology & pharmacotherapeutics with hand on expertise in clinical trials, medical writing, pharmacovogilance, clinical oncology and centralized clinical operations in global multicentric clinical trials. |
| 8 | Ali husen | Pharmacognosy and phytochemistry and Pharmaceutical jurisprudence | Neuroscience | Some key areas of focus in neuroscience include: 1. *Neural signaling*: Understanding how neurons communicate with each other. 2. *Brain development*: Studying how the brain develops and changes throughout life. 3. *Neuroplasticity*: Examining the brain’s ability to adapt and change. 4. *Neurological disorders*: Investigating the causes and treatments of conditions like Alzheimer’s, Parkinson’s, and stroke. 5. *Behavior and cognition*: Exploring the neural basis of behavior, perception, attention, and memory. |
| 9 | Ashish Kumar Nirmal | Hospital & Clinical Pharmacy | Cancer, Diabetic wound healing | Flavonoids found in various medicinal plants have potential for wound healing applications. Diabetic wounds are characterized by impaired healing due to chronic inflammation, oxidative stress and reduced angiogenesis. Research focuses on isolating flavonoids and evaluating it’s efficacy in promoting wound closure, Collagen synthesis, and reducing inflammation in experimental diabetic rat models. |
| 10 | Harshit Srivastava | Pharmaceutical Engineering | Pharmaceutics | Work on nano sponge gel formulation for anti psoriasis activity. |
| 11 | Wasim Akhtar | Pharmacology, Human anatomy and physiology | cerebral ischemia-reperfusion injury | Cerebral ischemia-reperfusion injury (CIRI) occurs when blood flow is temporarily restricted to the brain and subsequently restored, leading to neuronal damage. The interruption of blood flow causes a shortage of oxygen and nutrients, resulting in cellular injury. Upon reperfusion, the sudden influx of oxygen can exacerbate damage through oxidative stress, inflammation, and apoptosis. These processes contribute to the complexity and severity of the injury. Understanding the mechanisms of CIRI is crucial for developing therapeutic interventions. |
| 12 | Jyoti Singh | Pharmacognosy | Wound Healing activity | nan |
| 13 | Vipin Kumar Kashyap | Pharmacology, Biochemistry, | Cardiovasculer system ,Myocardial infraction | Effect of natural or synthetic compound on receptor of heart via molecular docking, |
| 14 | Santosh Kumar | Pharmaceutical Engineering, Pharmaceutical Biotechnology and Social Preventive Pharmacy | Herbal formulations and NDDS | I have completed B.Pharm and M.Pharm with Pharmaceutics specialisation and pursuing Ph.D with Pharmaceutical science . |
| 15 | Dr. Amit Kumar Pandey | Physical Pharmaceutics-I, Physical Pharmaceutics-II, Industrial Pharmacy ,Pharmaceutics-I and pharmaceutical engineering. | Novel Drug Delivery System | I have completed M.pharm from Dr. APJ Abdul kalam Technical University, Lucknow in the subject specialization pharmaceutics and completed phD from AKTU in pharmaceutical science. I have published 7 research paper in various national and Intrenational journals. |
| 16 | MANISHA SRIVASTAVA | MEDICINAL CHEMISTRY, INSTRUMENTAL METHODS OF ANALYSIS | SYNTHETIC MEDICINAL CHEMISTRY | Pursuing PhD from Integral University, Lucknow, Enrolled in 2021. My PhD topic is DESIGN SYNTHESIS AND ANTICONVULSANT ACTIVITY OF NOVEL BENZIMIDAZOLE DERIVATIVES. Taught courses in pharmaceutical chemistry, medicinal chemistry and Pharmaceutical Analysis. |
| 17 | Rabiya Ahsan | Human anatomy and Physiology. Pharmacology, Pathophysiology | Neurological disease, Neuroscience | Neurological diseases are disorders that affect the brain, spinal cord, and nerves. These conditions include Alzheimer’s disease (AD), Parkinson’s disease, epilepsy, and multiple sclerosis. They often result in cognitive, sensory, and motor impairments due to disrupted neural function. Causes can range from genetic mutations and infections to trauma and environmental factors. Early diagnosis and treatment are crucial for managing symptoms and improving patient outcomes. |
| 18 | Dr Samar Mujeeb | Pharmaceutical Analysis, Pharmaceutical Chemistry, | Heterocyclic chemistry, Synthetic Chemistry, Computer Aided Molecular Modelling | My primary area of interest is Drug design and heterocyclic chemistry. I have good knowledge of computational chemistry such as molecular docking and molecular simulations etc. I am well versed in the latest research practices and am always investigating ways to incorporate the latest advances in technology into my work. I am also working in collaboration with international researchers and have my papers in pipeline to be published. I have also applied for two projects currently in UPCST and ICMR. I am also in process of writing few more projects for future reference. |
| 19 | Dr. Kisalaya Mishra | Pharmacology, Pathophysiology, Human anatomy & Physiology | Neuroinflammation, Neurotoxicity | I am from Jaunpur Uttar pradesh. I have done my M.Pharm in 2013 ,& my PhD in 2024. I am GPAT 2011 qualified. Before joining the Hygia I was in Dr. MC Saxena college of Pharmacy Lucknow. I have 11 years of teaching experience. |
| 20 | Rahul Jaiswal | Pharmacology | Cardiomyopathy | I am a PhD research scholar specializing in Pharmacology, focusing on Cardiomyopathy. My work involves exploring the underlying mechanisms contributing to this group of heart muscle diseases that impair the heart’s ability to pump blood effectively. I aim to investigate genetic, molecular, and environmental factors influencing cardiomyopathy progression. The goal of my research is to identify potential therapeutic targets and develop effective treatments. Through this, I aspire to contribute to improving outcomes for individuals with cardiomyopathy. |
| 21 | Dr. Avani | Pharmaceutics, biopharmaceutics, Industrial pharmacy | Micro granulation, HPLC method validation, | Validation of HPLC method ,compatibility studies and stability indicating assay of pantoprazole sodium and it’s micro granulation by FBD and double pyloric ligation of GERD model in rats. |
| 22 | Dr. Shobha Singh | Advance organic chemistry-II, inorganic Pharmaceutical Chemistry | Natural product chemistry, Medicinal Chemistry | Ph. D specialization in natural product chemistry Expertise in isolation and modification of bioactive compounds Expertise on characterisation of organic compound by NMR and Mass Expertise on lipid chemistry and Carbohydrate chemistry |
| 23 | Dr. Shiv Bhadra Singh | Medicinal chemistry-I, Medicinal chemistry-II, Modern analytical techniques, | Inorganic chemistry | Synthesis of organobismuth compounds, their spectral analysis and biological activities like antimicrobial, anticancer and gastroprotective activities |
| 24 | Richa Tripathi | Pharmaceutics | Formulation and evaluation of silver nanoparticles containing Celasrtus orbiculatus extract for effective treatment of skin infection. | Silver nanoparticles have potential of antibacterial agent . Greenly produced silver nanoparticles have biomedical uses as well as the ability to inhibit harmful microorganisms. |
| 25 | Vivekanand Prajapati | NDDS | Formulation Development | Topic not decided |
| 26 | Nirankar Pandey | Pharmaceutical analysis -I organic chemistry Modern analytical techniques | Phytochemistry and analytical chemistry | 1.Specializes in teaching physical chemistry, pharmaceutical analysis organic chemistry and modern analytical techniques. 2.strong research background in phytochemistry, focusing on the isolation and analysis of bioactive compounds from natural sources 3.Proficient in organic chemistry, advanced analytical chemistry instrumentation and titration based analysis practicals. 4..Experienced in mentoring m.Pharm students in chemistry and analytical research. |
| 27 | Shweta mishra | Pharmaceutics | Bilosomes | Preparation and evaluation of naringenin based nanocarriers for ocular. |
| 28 | Mukesh Kumar Shukla | Pharmaceutics | Pharmaceutical Sciences | The PhD thesis focuses on the formulation and evaluation of nanosponge-based gel for the treatment of psoriasis using andrographolides, aiming to develop an advanced topical delivery system. Nanosponges, with their porous and sponge-like structure, are capable of encapsulating and stabilizing active pharmaceutical ingredients. |
| 29 | Dr. Asad Ali | Physical Pharmaceutics I, Cosmetic Science & Quality Assurance | Lipid Based Nanoformulation | Lipid-based nanoformulations, including liposomes, SLNs, NLCs, and nanoemulsions, enhance the solubility, stability, and bioavailability of poorly water-soluble drugs. They enable controlled release, targeted delivery, and reduced side effects, protecting drugs from degradation while improving absorption. Widely used in pharmaceuticals, cosmetics, and nutraceuticals, they show promise in treating chronic diseases like cancer, diabetes, and infections. |
| 30 | Shadab Alam | Pharmacognosy, Herbal drug technology | Pharmacognosy & Phytochemistry | standardization of Coccinia indica fruit, development and characterization of Coccinia indica fruit phytosomes, antidiabetic potential of developed phytosomes. |
| 31 | Shreya Talreja | Pharmacy | Pharmaceutical Chemistry | Design, synthesis and characterization of novel fused heterocyclic compound with the identification of anti-cancer activity. |
| 32 | Diksha Gupta | Pharmaceutics | Formulation and optimization | To develope and optimize the formulation |
| 33 | Ashfa Zubair | Pharmaceutics I | Ophthalmics | The study highlights safety profile of the herbal eye drop, revealing that they did not induce any irritation or harmful effects and validating the efficacy and safety of the herbal eye drop.This research not only reinforces the relevance of herbal formulations but also encourages further exploration into natural remedies for eye health and enhancing the therapeutic options available for management of eye diseases. |
| 34 | Dr Himani Awasthi | Advance pharmacology, molecular pharmacology, screening, HAP | Pharmacology | Working on neurodegeneration |
| 35 | Rajni Mishra | Pharmacognosy-I and II, herbal drug technology | Phytochemistry | 1)Working as an Associate professor in a college. 2) Total 10.6 years experience. 3) Department is Pharmacognosy. 4) Pursuing phd from Teerthanker mahaveer university, Moradabad.. |
| 36 | Anant kumar Shrivastava | Pharmacology II | Non alcoholic fatty liver disease | Amelioration of fatty deposition induced by high fat diet by using various herbal extracts. |
| 37 | Rajni Devi | Medicinal Chemistry | Pharmaceutical Chemistry | Computational studies of the compounds, Synthesis and characterization of the compounds, Biological activity of the synthesized compounds. |
| 38 | Naincy Gupta | Pharmaceutics | Formulation and development | Herbal formulation based on herbal plants.. |
| 39 | Ankur Gera | Medicinal Chemistry | Synthetic Chemistry and Characterization | nan |
| 40 | Samiksha Srivastava | Advance Medicinal Chemistry, Advance Spectral Analysis, Modern pharmaceutical Analytical techniques, Medicinal Chemistry, process Chemistry | Pharmaceutical Chemistry | I have 11 years of teaching experience. I’m Pursuing PhD from Shobhit University. Awarded M.pharm from PSIT Kanpur and B.pharm from Shambhunath Institute of pharmacy. |
| 41 | Dr. Mohd Murad Azami | Human anatomy and physiology | Hepatoprotective activity of polyherbal extract | nan |
| 42 | Asif Eqbal | Pharmaceutical Microbiology | Nano formulation | Nanoformulation refers to the development of nanoscale formulations to improve the delivery, efficacy, and stability of active pharmaceutical ingredients (APIs) or other bioactive compounds. It involves the use of nanotechnology to create structures like nanoparticles, nanocapsules, or nanoliposomes. These formulations enhance drug solubility, bioavailability, and targeted delivery while minimizing side effects. Nanoformulations are widely applied in medicine, agriculture, and cosmetics. They offer significant potential in addressing challenges like drug resistance and controlled release. |
| 43 | Dr. Pappu Kumar pal | Pharmacy practice | DUE of Panta prazolo inhibitors in hospital | Use of ppi in hospital and their side effects in long term use |
| 44 | Mohd Shaiber Siddiqui | Pharmaceutics I | Nanoemulsion | Nanoemulsions are stable colloidal dispersions of oil, water, and surfactants with droplet sizes typically below 200 nm. They are used to improve drug solubility, bioavailability, and controlled release. Nanoemulsions can be prepared using high-energy methods like ultrasonication or low-energy techniques like phase inversion. They have diverse applications in pharmaceuticals, cosmetics, and the food industry. Challenges include scalability, cost, and long-term stability. |
| 45 | Priyanka Mishra | Instrumental methods of Analysis, Pharmaceutical Biotechnology | Method Development, method validation, formulation, computational studies | My research topic is regarding Integration of computational studies against Type II diabetes and inflammation |
| 46 | Dr. Abhishek Gupta | Pharmacognosy | Natural products | Completed my Ph.D in October 2020 registered at BBD University, Lucknow while working as Young Scientist Fellow at CSIR NBRI. |
| 47 | Dr Dipti Srivastava | Modern pharmaceutics, Computer aided drug delivery | Cocrystal technique,nano drug delivery systems | Have worked on cocrystallization technique for solubility and bioavailability enhancement, have worked on nano vesicular and nano emulsion, also using DOE technique for formulation |
| 48 | Chandani nigam | Pharmacology | Hepato | Evaluation of antioxidant and hepatoprotective activity of Bougainvillea glabra and dracaena sanderiana on paracetamol induced hepatotoxicity in rats |
| 49 | Dr.Varsha Singh | Industrial pharmacy and drug delivery system | Pharmaceutics | Herbal and microspheres formulation development and evaluation techniques |
| 50 | Bhagyashree Goswami | Pharmaceutical Organic Chemistry, Pharmaceutical Inorganic Chemistry, Medicinal Chemistry, Instrumental Methods of Analysis | Synthesis and computaional | Pursuing my phD from Bansthali Vidyapith and completed my M.pharm from Central University of Rajasthan. Working on anticancer activity with heterocyclic compounds. I have 4 publication including one research paper in Tetrahedron letters and other in socpus indexed and Web of science. |
| 51 | Dr. Arvind kumar | Pharmaceutical Inorganic Chemistry | Antifungal activity | The aim of this work is to evaluate the antifungal activity and related active principles of the herbal plant extract of cymbopogon winteranus. |
| 52 | Preety Gautam | Novel drug delivery system, pharmacovigilance, cosmeceuticals, social and preventive pharmacy, industrial pharmacy, physical pharmacy, biopharmaceutics | Nano formulation, herbal formulations ,topical formulation | I have 4 research publications and 2 patent publications. I have qualified gpat 2020. I am currently pursuing phD from DIT University(thesis submitted). I have presented various poster and oral presentation in both national and international conferences. |
| 53 | Udaivir singh sara | Pharmaceutics PG | Controlled drug delivery systems | Studies on few drug delivery systems of anticancer drugs |
| 54 | Dr. Reetu | Pharmaceutics, Novel Drug Delivery System, Marketing | Pharmaceutics (Cocrystallization) | I have completed my PhD from K.R. Mangalam University, Gurugram in 2022. |
| 55 | Rahul Kulshrestha | Industrial Pharmacy-I, Biopharmaceutics, Novel Drug Delivery System, Industrial pharmacy-II, Dietary Supplement and Nutraceuticals, Regulatory affairs. | Insitu Gel | Formulation & evaluation of oral in-situ Gel for rapid relief in herpangina in Diabetic children. |
| 56 | Palak Shukla | Pharmaceutical analysis | Synthesis and computational | My work involves developing and evaluating the effects of thiazolidinone nucleus-based compounds on specific cell lines. Thiazolidinones are heterocyclic molecules with promising therapeutic potential, including anti-cancer, anti-inflammatory, and antimicrobial activities. It focus on synthesizing these compounds and studying their biological interactions, mechanisms, and cytotoxicity in vitro. This includes analyzing molecular pathways influenced by the compounds in various cell lines. The goal is to identify and optimize novel thiazolidinone derivatives for targeted therapeutic applications. |
| 57 | Sabreena Naz | Pharmacy practice, Human Values | Nephroprotective agents and Neurotoxicity and its treatment methadology. | My research interest was on nephrotoxicity while in masters, and later the neurotoxicity and its treatment. Currently I have 5 research articles on the neurotoxicity and its treatment procedures and have submitted my thesis for final viva. |
| 58 | Mr. Nirankar Pandey | Pharmaceutical analysis -I organic chemistry Modern analytical techniques | Phytochemistry and Analytical chemistry | nan |